Publications

Publications

Filter Results: (483) Arrow Down

Show Results For

← Page 10 of 483 Results →
  • June 2003 (Revised March 2008)
  • Case

Schering-Plough and Genome Therapeutics: Discovering an Asthma Gene

By: Regina E. Herzlinger and Marc Aquino
Personalized medicine requires the identification of mutated genes. Schering-Plough's search for the one related to asthma requires finding families with the disease. Examines the industry that helps conduct such research, including contract research organizations. View Details
Keywords: Health Disorders; Research and Development; Genetics; Pharmaceutical Industry; Pharmaceutical Industry
Related
  • Web

Hiring Organizations

Benchstrength Berkeley Research Group LLC Berkshire Partners BHP Biogen BJ's Wholesale Club Blackhorn Ventures BlackRock Blackstone Blank Street Blitzy AI Bloomberg Center for Cities at Harvard University Bloomberg Harvard City Leadership... View Details

    William A. Sahlman

    William Sahlman is a Baker Foundation Professor of Business Administration at Harvard Business School.

    Mr. Sahlman received an A.B. degree in Economics from Princeton University (1972), an M.B.A. from Harvard University (1975), and a Ph.D. in Business... View Details

    Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals

      Nitin Nohria

      Nitin Nohria served as the tenth dean of Harvard Business School from 2010-2020. He previously served as co-chair of the Leadership Initiative, Senior Associate Dean of Faculty Development, and Head of the Organizational Behavior unit.

      As Dean, building on... View Details

      Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals
      • 23 Jun 2003
      • Research & Ideas

      Historically Speaking: A Roundtable at HBS

      faculty, whose scholarship and teaching skills attract hundreds of Harvard MBA students to their classrooms each year. Among the latest books by HBS historians are publications by Professor Chandler, Professor Nancy Koehn, and Professor Richard Tedlow. Leading View Details
      Keywords: by Jim Aisner

        W. Carl Kester

        Carl Kester is a Baker Foundation Professor and the George Fisher Baker Jr. Professor of Business Administration, Emeritus at Harvard Business School. He is a member of the Finance Unit. He served as Deputy Dean for Academic Affairs (2006-2010), Chairman of the... View Details

        Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals
        • January 2024
        • Supplement

        Accounting Red Flags or Red Herrings at Catalent? (B)

        By: Joseph Pacelli, ZeSean Ali and Tom Quinn
        GlassHouse Research identified accounting red flags at Catalent. Fiat Lux Partners countered most of GlassHouse’s claims. Who was right? This update explores the aftermath of the short seller duel. View Details
        Keywords: Accounting Audits; Acquisition; Budgets and Budgeting; Business Earnings; Earnings Management; Cost Accounting; Fair Value Accounting; Financial Reporting; Revenue Recognition; Integrated Corporate Reporting; Fairness; Moral Sensibility; Values and Beliefs; Government Legislation; Conflict of Interests; Announcements; Blogs; Debates; Lawsuits and Litigation; Stocks; Performance Productivity; Pharmaceutical Industry; Pharmaceutical Industry; United States
        Related
        • 04 Apr 2022
        • Research & Ideas

        Tech Hubs: How Software Brought Talent and Prosperity to New Cities

        An explosion in software patents within the last 50 years fueled the rise of America’s six major tech hubs, but also siphoned talent from some of the nation’s biggest cities, new research finds. The transition to six major hubs—San... View Details
        Keywords: by Rachel Layne
        • Research Summary

        Overview

        I am interested in the individual experience of learning in organizational settings, particularly how employees learn to learn from the challenging work they do. I am currently researching the role of reflection for raising awareness of learning opportunities that... View Details
        Keywords: Learning; Learning And Development; Learning Organizations; Intrinsic Motivation; Reflection; Goal Setting; Performance Measurement; Innovation; Job Design; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry
        • Research Summary

        Career Histories and the Biotechnology Industry

        Professor Higgins' other major project focuses on the consequences of individuals' career experiences for firms and industries. This second research stream centers on the careers of executives in the biotechnology industry.

        Professor Higgins has written... View Details

        • 25 Jul 2023
        • Research & Ideas

        Could a Business Model Help Big Pharma Save Lives and Profit?

        cross-sector and cross-border partnerships needed to execute the model. Adding new information about how pharmaceutical companies handle global public health challenges. Jessica Martinez, a former Big Pharma executive who joined the Bill... View Details
        Keywords: by Esther Schrader; Pharmaceutical; Pharmaceutical
        • 22 Jan 2014
        • Working Paper Summaries

        Separating Homophily and Peer Influence with Latent Space

        Keywords: by Joseph P. Davin, Sunil Gupta & Mikołaj Jan Piskorski
        • 01 Jun 2009
        • Lessons from the Classroom

        The Challenges of Investing in Science-Based Innovation

        In economic downtimes, businesses are apt to cut R&D projects that don't promise a speedy return on investment. But take a cue from smart science-based businesses, which view the recession as an opportunity to stoke up research and... View Details
        Keywords: by Julia Hanna; Pharmaceutical; Pharmaceutical; Pharmaceutical

          Willis M. Emmons

          WILLIAM (WILLIS) EMMONS is Senior Lecturer and Director of the C. Roland Christensen Center for Teaching and Learning at Harvard Business School, a position he has held since 2004.  As Director of the Christensen Center, Emmons oversees programs to... View Details

          Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals
          • 20 Nov 2007
          • First Look

          First Look: November 20, 2007

          discipline to nationalized banks. Pharmaceutical Regulation in the United States and Europe Author:Arthur Daemmrich Periodical:Focus on Law Studies 23, no 1 (fall 2007): 8-11 Read the full paper:... View Details
          Keywords: Martha Lagace
          • 10 Oct 2007
          • First Look

          First Look: First Look: October 10

          We investigate these research questions in the context of the U.S. Environmental Protection Agency's Audit Policy. Download the paper: http://www.hbs.edu/research/pdf/08-021.pdf   Cases & Course MaterialsGianna Angelopoulos-Daskalaki... View Details
          Keywords: Martha Lagace
          • Research Summary

          Overview

          Dr. Crawford conducts research on innovation in the energy industry, with a special focus on emerging business models. She is developing several cases for the EC course, "21st Century Energy," that specifically examine innovations at the interface of IT and Energy — ... View Details
          Keywords: Electricity; Prosumer; Smart Grid; Blockchain; Microgrid; Electric Vehicles; Batteries; Energy Storage; Ride-sharing; Smart Cities; Smart Buildings; Smart Meters; Demand Response; ＂GMOs,＂; Corporate Accountability; Responsibilities To Society; Environmental And Social Sustainability; Leadership & Corporate Accountability; Competitive Strategy; Innovation Strategy; Disruptive Innovation; Research and Development; Leadership; Environmental Sustainability; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Europe; Asia; United States
          • 13 Jun 2005
          • Research & Ideas

          From Turf Wars to Learning Curves: How Hospitals Adopt New Technology

          several reasons. First, we both had been involved with prior research in hospitals and found them to be fascinating organizations. They are filled with highly trained professionals working in team settings on a regular basis. What's more,... View Details
          Keywords: by Sara Grant; Health
          • February 2010 (Revised April 2010)
          • Case

          Organization and Strategy at Millennium (A)

          By: Julie M. Wulf and Scott Waggoner
          This case examines Millennium's strategic and organizational responses to the rapid evolution of the biopharmaceutical industry. In the early 2000s, as Millennium's competitive advantage in early-stage research slipped away and its losses mounted, founder and CEO Mark... View Details
          Keywords: Transformation; Leading Change; Management Succession; Organizational Change and Adaptation; Competitive Strategy; Competitive Advantage; Pharmaceutical Industry; Pharmaceutical Industry
          Related
          • Research Summary

          Overview

          My focus is empirical financial accounting research, with particular interests in governance, valuation, M&A, and short-sellers. All three of my papers to date fall under the broad heading of “alternative governance mechanisms”—studies of how accounting information is... View Details
          Keywords: Mergers and Acquisitions; Corporate Governance; Valuation; Law